This study reveals acetylcholinesterase and tyrosinase inhibition in Allium semenovii, suggesting its antioxidant properties.
Seven compounds [palmitaldehyde (1), daucosterol (2), 24-propylcholesterol (3), asperin (4), vanillic acid (5), paprazine (6), and cycloalliin (7)] were isolated and characterised from aerial part of Allium semenovii Regel for the first time. Extract, fractions, and isolated compounds were assessed for antioxidant, acetylcholinesterase and tyrosinase enzyme inhibition activities. A maximum antioxidant potential was observed in compound 6 (IC50 =12.45 ± 0.69 µM, ABTS•+ and 377.67 ± 0.10 µM, DPPH•) followed by ethyl acetate (IC50 = 95.00 ± 0.15 µg/mL, ABTS•+) and chloroform fraction (IC50 = 370.00 ± 0.6 2 µg/mL, DPPH•). Chloroform fraction (IC50 = 172.50 ± 0.70 µg/mL) and compound 4 (IC50 = 108.01 ± 1.99 µM) showed higher acetylcholinesterase enzyme inhibition. Whereas, Compound 5 was found significant to inhibit tyrosinase enzyme (IC50 = 11.37 ± 0.16 µM). Hence, study suggested therapeutic potential of A. semenovii which could be due to presence of diversified compounds.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: